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INTERNATIONAL COOPERATIVE 

STUDY ON DRUG USE IN PREGNANCY 

RESULTS FROM MALTA 

This study was conducted under the 
auspices of the W.H.o. and was supported 
in part by the National Research Council 
'Convenzione Farmacologia Clinic' 
(Italy). 
INTRODUCTION 
The risks of teratogenesis and other 
adverse effects on the neonate have 
created a cautious attitude towards the 
use of drugs during pregnancy. It is 
generally believed that drug intake in 
pregnancy is high and variable in different 
countries, but the quality of prescriptions 
and use of drugs by the majority of 
physicians and women has by no means 
been adequately clarified (1). To identify 
the pallern of drug use in pregnancy a 
collaborative network was set up by 
WHO·IRO to collect comparable data on 
a population large enough to represent 
the current situation across various 
'culturaI' and health care settings. This 
epidemiological collaboration study 
allows not only for an international 
assessment of drug usage during 
pregnancy and the puerperium, but also 
enables inter-country differences to be 
identified. This study auempts to correlate 
drug usage during pregnancy in Maltese 
women to the trends identified in the 
International Cooperative Drug utilization 
Study (2, 3). 
MATERIAL AND ME'lHODS 
An international cooperative network was 
set up involving 131 hospitals 
representing 19 countries. In each 
participating country a clinical 
pharmacology unit and/or an obstetrics 
department acted as a reference center for 
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a group of hospitals representing various 
levels of care. The maximum expected 
enrolled number of deliveries for each 
country was 0.1 % of the number of live­
births per annum. A total of 12605 
deliveries were enrolled by December 
1989. The Department of Obstetrics and 
Gynaecology at Karin Grcch Hospital 
(Malta) participated by enrolling 100 
deliveries occurring during the period 8 ­
16 October 1987 accounting for 1.8% of 
all the deliveries registered in the Maltese 
Islands that year. The general organization 
for the International Cooperative Study 
has been previously described (4). 
Women were interviewed in the first week 
after delivery using a simple structured 
standardiznl questionnaire, a method that 
has been shown to be reliable and accurate 
for obtaining recalled pregnancy-related 
events including drug exposure (5). In 
addition the hospital ftIes were reviewed 
so that hospital use of drugs could be 
assessed. A detailed descriptive list of 
prescribed drugs in Maltese pregnant 
women has been elsewhere reported (6). 
RESULTS 
The rnajority of Maltese pregnant women 
(99%) received some form of medication 
sometime during their pregnancy, the 
larger proportion (96.97%) receiving 
drugs during the antenatal period while 
75.76% and 62.63% received drugs during 
the intrapartum and postpartum periods. 
More medications were prescribed 
however during the lauer two periods 
than during the antenatal period (fable 
1). These figure compared to the 
international trends suggest that during 
the antenatal period a larger percentage 
of women receive some form of 
prescription when compared to the overall 
group. The mean number of drugs taken 
per patient is however less in Maltese 
patients at any time during pregnancy. 
During the antenatal period therefore only 
4% of Maltese women received no form 
of medication. This contrasts with the 
figure of 13% in the overall group and is 
similar to the prescribing trends in Ireland 
(2%), Finland (3%), Brazil (6%), Sri 
Lanka (1 %), India (3), Panama (0%) and 
Ghana (0%). The percentage of non-drug 
takers during the antenatal period by 
participating country is shown in Figure 
1. Czechoslovakia and G.DR. appeared 
to have the larger percentage of non-drug 
takers with 36% and 39% respectively. 
Drug taking during the antenatal period 
appears to be more common in Maltese 
pregnant women when compared to the 
international mean, though the mean 
number of drugs taken per woman appears 
to be markedly reduced. This high drug 
intake during the antenatal period appears 
to result from more frequent 
haematological prescriptions, these 
accounting for 54.2% of all prescriptions 
given to 90.6% of all mothers. These 
figures contrast with those of the 
international group where hrematological 
prescriptions accounted for 25% of all 
prescriptions given to 64% of mothers 
(Table 2). The haematological 
prescription habits of different countries 
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FIGURE 1: POPULATION PROFILE: NON-DRUG TAKERS ANTENATAL PERIOD 
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FIGURE 2: PERCENTAGES OF WOMEN TAKING HAEMATOLOGICALS 
Maltese Medical Journal Volume IT Issue IT 90!919 
partiCipating in the study suggests that 
prescription of haemal.Ologicals is most 
frequent in Malta (Figure II). The intake 
of all other class of medication appeared 
1.0 be markedly reduced in the Maltese 
group, while anti-infective agents appear 
1.0 have been given to a similar proportion 
of mothers in both groups (Table 2). 
1bc number of women receiving drugs 
during the period between hospital 
admission and delivery appeared 1.0 have 
been reduced from 80.0% in the overall 
group to 75.76% in the Maltese population 
with only a minimal decrease in the mean 
number of drugs taken per patient these 
prescriptions were indicated for analgesia 
or general anaesthesia (67.3% of 
prescriptions), 1.0 augment"or delay labour 
(26.5%) and a minority were prescribed 
for a variety of indications and iflcluded 
anti-infectives, anti- hypcrtensives, anti­
emetics/antacids, tranquillizers and 
corticosteroids. 
In the third stage of labour and the 
peurperium until discharge from hospital 
62.63% of Maltese women received some 
form of medication with a mean of 2.19 
drugs per patient This figure contrasts 
with the higher rate of 79.2% and a mean 
number of drugs of 2.917 in the overall 
study population (Table 1). All the 
Maltese women receiving medication 
were planning to breastfeed, while only 
92.6% of the international group receiving 
drugs were planning to do so. Initial 
breastfeeding rates vary from one country 
1.0 another. In the Maltese population the 
initial breastfeeding rate was 64%. The 
medications most frequently prescribed 
in the Maltese group (Table 3) were the 
endocrinologicals (49.9% of prescriptions 
given to 95.2% of women) and the 
anaesthetics (36.8% of prescriptions given 
to 80.7% of women), rates which are 
markedly in excess to those prescribed in 
the international group (7% of prescription 
given 1.0 20% of mothers, and 2% of 
prescriptions given to 6% of women 
respectively). Identification of these drugs 
to the principle shows that these 
prescriptions referred 1.0 synl.Ometrin and 
lignocaine administered after delivery of 
the child to prevent pos-partum 
haemorrhage and enable perineal suturing. 
The relative low rate in the international 
group may reflect the general inclusion of 
these drugs as part of the labour process 
rather than as part of the early peurperium. 
AIl other drug classes in the Maltese 
group were prescribed at a markedly lower 
frequency than in the overall international 
group (Table 3). 
DISCUSSION 
Knowledge of how 1.0 handle drugs in 
pregnancy is still limited and the 
participating health professional is in any 
case unlikely to be in possession of all the 
known facts. Often a woman is merely 
advised 1.0 avoid drugs all.Ogether when 
she becomes pregnant and if teratogenic 
drugs have already been take abortion 
may be recommended where this is legally 
permissible. Prescribing habits to 
pregnant women vary from one country 
to another. Reliable comparative data on 
drug usage in pregnancy is largely lacking 
and even regional or local figures tend 1.0 
be incomplete or outdated. While drug 
usage in pregnancy appears to have 
decreased over the last three decades after 
the thalidomide experience, it appears 
that the current level of drug usage is in 
excess of what one would expect Drawing 
on the experience of WHO which has 
documented the importance of systematic 
surveys in the extent and quality of drug 
use in various countries, an 
epidemiological collaborative study was 
initiated primarily to assess the pattern of 
drug use in pregnancy over a predefmed 
period from sample hospitals in different 
countries (4). The study showed marked 
intra- and inter-country differences in 
prescribing habits and the observed drug 
use proftle differed significantly from the 
picture obtained from the literature, 
suggesting that practices are continually 
shifting under the combined in.fJuences of 
variables such a'> time and country (3). 
Prescribing habits in Malta during the 
antenatal course of pregnancy may be 
said to be conservative even though a 
large proportion of women received some 
form of medication. Pregnant Maltese 
women received from 1-2 prescriptions 
during the antenatal period, the larger 
proportion being haematologicals. All 
other medications, except the anti­
infectives, were prescribed at a marked 
lower raIC. Haemal.Ological prescriptions 
1.0 antenatal patient'> have been shown to 
vary from country 1.0 country varying 
from 15% of women in Yugoslavia 1.0 
90.6% of women in Malta (3). The value 
of routine oral iron supplementation in 
pregnancy remains controversial and it 
appears that such a widely used therapy 
does not seem necessary for the majority 
of healthy pregrumt women in a developed 
country (7). The incidence of anaemia 
(Hb under 109/d!) in the Maltese pregnant 
population approximated 0.7% of all 
deliveries in 1983-1986 (8). The 
conservative practices regarding other 
medicament'> reflect in part the critical 
attitude of hcalth care professionals in 
Malta and also 1.0 a similar suspicious 
attitude by the pregnant woman herself. 
Patient awareness of the adverse effects 
of drugs is reflected by reluctance 1.0 take 
medication even when correctly 
prescribed and by their attitudes l.Owards 
smoking on discovering they were 
pregnant when 63.4% attempted to stop 
(9). Excluding the administration of 
haematologicals and metabolic­
nutritional supplements, all other 
medicaments were prescribed for a 
number of medical disorders pre-existing 
or appearing during pregnancy, to alleviate 
minor symptoms and 1.0 manage specific 
obstetric problems such as habitual 
abortion and pretcrm labour (6). 
Intra-hospital prescnpuons before and 
during delivery show an overall similarity 
to the international group, with the 
majority of drugs being prescribed 1.0 
influence the progress of labour and as 
intrapartum analgesia. The high 
proportion (75.76%) of women receiving 
medications and the high mean number 
of drugs per patient (3.17) reflect the 
active intraparum management policy 
practised in the hO~'Pital. The use of 
intrapartum analgesia and intra-operative 
anaesthesia in Maltese women ha,> been 
previously reviewed (10). The use of 
systemic analgesia and anaesthesia was 
shown to be a<;sociatcd with depressed 
Apgar scores of the infants, though this 
may not have been the result of a direct 
association with drug usage. A few 
intrapartum prescriptions were 
administered for maternal conditions pre­
existing during pregnancy or occurring in 
the intra-partum period. Dexamethasone 
and salbutamol were administered for 
foetal indications to delay labour and 
stimulate lung surfactant production in 
cases of preterm labour. Other 
medications given after the birth of the 
child include the administration of 
oxytocics to prevent postpartum 
haemorrhage and local anaesthetics for 
perineal suturing. Drugs appear to be 
rarely preseribed 1.0 the lactating female 
in the early peurperium. 
--- - -- -------
- -- ----
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CONCLUSION 
This study has shown that, except in the 
ca<;e of the prophylactic administration of 
haematologicals during the antenatal 
period <md the intrapartum prescriptions 
to manage labour actively, the majority of 
pregnant women and health care 
professionals in Malta have a conservative 
attitude towards drug prescription in 
pregnancy and lactation lL,>ing medications 
only when they are considered essential. 
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TABLE 1 : DRUG THERAPY DURING DIFFERENT CONSIDERED PERIODS 
DRUG THERAPY Maltese Population International study 
No of drug Mam no No of drug Mam no 
takers (%) of drugs takers (%) of drugs 
/patient /patient 
Started before and 
continued during 
pregnancy 4 (4,04) 1.75 526 (4.2) 1.481 
Started during 
pregnancy 95 (95,96) 1.86 10840 (87,0) 2.849 
During pregnancy 
up to hospital 
admission for delivery 96 (96.97) 1.77 10829 (87.7) 2,897 
Between hospital 
admission & delivery 75 (75.76) 3.17 9966 (80.0) 3.423 
In the pucrperiwn: 
-all women 62 (62.63) 2.19 9867 (79.2) 2.917 
-breast fceders 62 (62.63) 2.19 9132 (73 .3) 2,958 
Whole pregnancy 99 5.57 12463 7.587 
-
I 
-
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TABlE 2: MEDICATIONS GIVEN DURING PREGNANCY UP TO 

HOSPITAL ADMISSION FOR DELIVERY 

CLASS MALTESE POPULATION INTERNATIONAL STUDY 
No of mothers (%) No of mothers (%) 
Haemetologicals 87 (90.6) 7004 (64) 
Metabolic - nutritionals 28 (29.2) 5959 (54) 
Autonomic nervous system 
drugs 7 (07.3) 2405 (22) 
Anti-infections 19 (19.8) 2136 (19) 
Analgesics, antipyretics 3 (03.1 ) 1890 (17) 
Immunoligicals 0 ( - ) 1676 (15) 
Gastrointestinals 6 (06.3) 1364 (12) 
Endocrinologicals 2 (02.1 ) 995 (09) 
Central nervous system drugs 1 (01 .0) 631 (06) 
Cardiovasculars 3 (03.1 ) 496 (04) 
Respiratory system drugs · 2 (02.1 ) 392 (04) 
Miscellaneous 2 (02.1 ) 345 (03) 
Coadiuvants 0 ( - ) 333 (03) 
Anaesthetics 0 ( - ) 37 (- ) 
Unknown, unclassified 0 ( - ) 480 (04) 
Total number of women 
receiving drugs 96 10929 
TABlE 3: 	 DRUGS TAKEN IN BREASTFEEDING (Current or planned) 
WOMEN 
CLASS 	 MALTESE INTERNATIONAL 
POPULATION GROUP 
No of women (%) No of women (%) 
Autonomic nervous system 6 (9.7) 5302 (58) 
Analgesics, antipyretics 3 (4.8) 3702 (40) 
Metabolics, nutritionals 0 ( - ) 3098 (34) 
Anti-infections 4 (6.5) 2963 (32) 
Haemetologicals 0 (- ) 2578 (28) 
Endocrinologicals 59 (95.2) 1852 (20) 
Gastrointestinals 2 (3.2) 943 (10) 
Anaesthetois 50 (80.7) 584 (06) 
Central nervous system drugs 2 (3.2) 596 (06) 
Cariovasculars 2 (3.2) 236 (02) 
Immunogicals 3 (4.8) 266 (03) 
Coadiuvants ( - ) 174 (02) 
Miscellaneous 0 ( - ) 145 (01 ) 
Respiratory system drugs 0 ( - ) 93 (01 ) 
Unknown - undassffied ( - ) 9 (- ) 
Total 	 62 9132 
The copyright of this article belongs to the Editorial Board of the Malta Medical Journal. The Malta 
Medical Journal’s rights in respect of this work are as defined by the Copyright Act (Chapter 415) of 
the Laws of Malta or as modified by any successive legislation. 
Users may access this full-text article and can make use of the information contained in accordance 
with the Copyright Act provided that the author must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the prior permission of the copyright 
holder. 
This article has been reproduced with the authorization of the editor of the Malta Medical Journal 
(Ref. No 000001) 
 
